Get the Stockscreener App
6.58
3.46%
0.22
Aspire Biopharma Holdings Inc stock is traded at $6.58, with a volume of 175.26K.
It is up +3.46% in the last 24 hours and down -1.50% over the past month.
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
See More
Previous Close:
$6.36
Open:
$6.54
24h Volume:
175.26K
Relative Volume:
0.24
Market Cap:
$8.52M
Revenue:
$34,600
Net Income/Loss:
$-11.76M
P/E Ratio:
-0.0428
EPS:
-153.5649
Net Cash Flow:
$-6.21M
1W Performance:
+9.67%
1M Performance:
-1.50%
6M Performance:
-94.53%
1Y Performance:
-98.28%
1-Day Range:
$5.66
$6.58
1-Week Range:
$4.45
$6.99
52-Week Range:
$3.309
$1,050.36
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
Name
Aspire Biopharma Holdings Inc
Sector
Industry
Phone
561-704-8527
Address
23150 FASHION DRIVE, SUITE 232, ESTERO
Compare ASBP vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
6.58 | 8.52M | 34,600 | -11.76M | -6.21M | -153.56 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Aspire Biopharma Holdings Inc Stock (ASBP) Latest News
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
ASBP Stock Back On Retail Radar After 78% Crash – Bulls Eye $1 Comeback - Stocktwits
Aspire Biopharma Holdings Inc (ASBP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue - ACCESS Newswire
Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th - The Manila Times
Aspire Biopharma Holdings Inc (ASBP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aspire Biopharma Holdings Inc - TradingKey
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - South Bend Tribune
LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff? - Stocktwits
Aspire Biopharma Holdings Inc (ASBP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ASBP Falls As Aspire Biopharma Bets $30M On Auto Deal - timothysykes.com
Aspire Biopharma Holdings, Inc. Files Form 8-K With SEC Detailing Other Events and NASDAQ Listing - Minichart
Trending Stocks Today | Aspire Biopharma up 6.03% Post-Market - Moomoo
Aspire Biopharma adjourns shareholder meeting due to lack of quorum - Investing.com UK
Aspire Biopharma adjourns shareholder meeting due to lack of quorum By Investing.com - Investing.com India
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
ASBP Jumps As Aspire Biopharma Attracts High-Volume Trading - timothysykes.com
Aspire Biopharma Stock Chops After Volatile Spike - StocksToTrade
ASBP - Finviz
Aspire Biopharma Agrees to Buy Dura Driver Control Systems - Moomoo
ASBP Stock Draws Trader Focus As Volatility Spikes - StocksToTrade
Aspire Biopharma Holdings (ASBP) Stock: Slides After $30M DCS Acquisition Deal - parameter.io
Aspire Biopharma to Acquire Dura Driver Control Systems - TipRanks
Aspire Biopharma to Acquire FireFish Driver Control Systems Business for $30 Million, Plus Adjustments - TradingView
Aspire Biopharma Acquires Automotive Supplier Dura Driver Control Systems in $30M Deal (ASBP) - Yahoo Finance
ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier? - TradingView
Aspire Biopharma Stock Is Sliding Today: What's Going On? - Benzinga
Aspire Biopharma signs definitive SPA to acquire Dura Driver Control Systems - TipRanks
Aspire Biopharma to acquire auto parts maker for $30 million - Investing.com
Aspire Biopharma Agrees to Acquire Dura Driver Control Systems for $30 Million; Shares Surge Pre-Bell - marketscreener.com
Aspire Biopharma to acquire auto parts maker for $30 million By Investing.com - Investing.com Canada
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - GoUpstate
Aspire Biopharma Holdings Warrant (ASBPW) Remains Under Pressure at $0.02Fast Moving Stocks - newsline.com
Aspire Biopharma Issues Shareholder Letter - ACCESS Newswire
ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill
Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members - ACCESS Newswire
Aspire Biopharma Surges 18% as Bullish Momentum Builds Toward Key ResistanceVolume Nodes - newsline.com
Aspire Biopharma announces $5m share buyback, DCS acquisition By Investing.com - Investing.com India
Aspire Biopharma announces $5m share buyback, DCS acquisition - Investing.com UK
Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empow - The National Law Review
Aspire Biopharma Faces Sharp Decline, Testing Key Support LevelsSector Neutral Pair - thelegaladvocate.com
Aspire’s Buzz Bomb partners with EoS Fitness gym chain - Investing.com UK
Aspire’s Buzz Bomb partners with EoS Fitness gym chain By Investing.com - Investing.com South Africa
Under-the-tongue caffeine sticks to reach EoS gym members - Stock Titan
Aspire Biopharma Holdings Inc Stock (ASBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):